The latest market research on global celiac disease has been released. This research entitled "Global Celiac Disease Drugs Market 2017-2021" was made available on the Research and Markets' offering website. The report predicts that the the drug market for celiac disease will grow on a global scale at a rate of 24.22 for a time period of 2017 – 2021. It also includes and shares granular analysis of the global market share, revenue forecasts, segmentation as well as geographic regions of the market.
With much analysis, the Global Celiac Disease Drugs Market 2017 – 2021 report has been produced with a vast and detailed market analysis at its roots along with input and knowledge from main experts in the industry. It a professional analysis around the status of the market of celiac disease drugs market manufacturers. It’s a great resource of information and guidance for individuals and companies interested in gaining information on celiac disease and its market trends.
Market trends for celiac drug growth
Market landscape (trend) and the growth that is projected during the next years, as well as the major vendors of the market, is widely analyzed.
Inorganic growth strategies (such as global mergers and acquisitions, regional acquisitions, and partnerships) are one of the key market trends which is likely to lead to a growing global drug market for drugs for celiac disease.
The presence and growing awareness of celiac disease is also driving an increase in the market. The report expresses that celiac disease is at large and it is hypothesized that the disease will continue to remain at large in the future because of high dependence on several gluten-containing foods and until now there is no specific drug to treat this disease.
Consumption of foods like pizza, beer, coke, and bread is at all-time high thus increasing gluten deposited in the body. Factors like increase in per capita income, addition towards junk food & beverages, lifestyle change and “ready –to-use packaged eateries” contributes to the rise in foods containing gluten.
The consequences caused by gluten food is to damage the inner lining of the small intestines.
Since there is no known cure for celiac, the only safest way celiac individuals can opt is to use gluten-free diet in order to improve their quality of life.
Global Celiac Disease Drugs Market 2017-2021 report also states that long-term sustainability is another challenge in the market. This is a great challenge as individuals with this disease must rely strictly on the gluten-free type of food in order to avoid the switch of the immune system response to gluten foods. Some anti-inflammatory and immunosuppressant drugs are available as well as nutritional supplements that may be taken as off-label types of therapy for celiac disease. However, they are only to be used as a second form of treatment.
Furthermore, the report expresses that new products are launching and this is showing another market trend. Yes, constant change is essentially needed for the success of the gluten-free market. This can includes both process or product. Increasing nutrition and enhancing flavor, some food manufacturers blend amaranth and quinoa into their gluten-free products. This approach brings new products into the market.
More people are learning about the health benefits of gluten-free food, and this is also a key factor in market drive. Products which are gluten-free are healthy for the digestive system in people with celiac. From research, using gluten-free products regularly will bring about many health benefits included decreased gas and bloating as well as having more energy. Statistics show that major improvement was observed mostly in children with autism and individuals who are sensitive to gluten.
Moreover, Global Celiac Disease Drugs Market 2017-2021 report states that there are challenges in the market like high prices. Gluten-free products (packaged food) are a good option for those with celiac disease or gluten intolerance, but their price is concerning for global consumers. The reason why such prices are high is due to the high cost of production. It’s an expensive process to replace wheat with other alternative gluten-free grains. This kind of alternatives increases costs. From the market, some of the gluten-free products are priced at 200% more than the normal product price which is so expensive to the gluten-free consumers.
Government initiatives is also another factor contributing to the growth of the global celiac disease drugs market. Governments of various countries including Australia, Argentina, Canada, New Zealand, the EU and the UK are fuelling the market with initiatives to treat celiac disease. Such initiatives are by funding the research or improving awareness or providing Therapeutics at subsidized prices.
Argentina has implemented "National Program for the Detection and Control of Celiac Disease" which will improve awareness and knowledge regarding Celiac disease like imposing labeling restriction for all gluten-rich packaged food just like Canada.
Market dynamics involves the following notable points
- There is an increase in gluten-free options in restaurants.
- There is consistent growing awareness about health benefits of gluten-free consumption.
- There is also an increased prevalence of health issues like celiac disease and other gluten allergies.
Market challenges as depicted from the report show that high prices, stringent regulations as well as contamination issues which lead to product recalls are key challenges involved in the market. Market trends involve new product launches, growing marketing activities to create awareness by major brands as well as an increased availability of gluten-free food in the market.
From the Celiac Disease Drugs Market report, key vendors include:
- General Mills
- Dr. Schär
- Hain Celestial Group
- Freedom Foods
Other prominent vendors listed from the report are:
- Bob's Red Mill Natural Foods
- Amy's Kitchen
- Boulder Brands
- Aleia's Gluten Free Foods
- Doves Farm
- Enjoy Life Foods
- Kraft Heinz Company
- Blue Diamond Growers
Companies mentioned include
- Innovate Biopharmaceuticals
- Johnson & Johnson
- Bristol-Myers Squibb
- F Hoffmann-La Roche
- LFB Group
- ADMA Biologics
- Anthera Pharmaceuticals
- Takeda Pharmaceutical
Key topics covered in the report
- PART 01: Executive summary
- PART 02: Scope of the report
- PART 03: Research Methodology
- PART 04: Introduction
- PART 05: An overview of celiac disease
- PART 06: Market landscape
- PART 07: Pipeline landscape
- PART 08: Market segmentation by therapy type
- PART 09: Geographical segmentation
- PART 10: Decision framework
- PART 11: Drivers and challenges
- PART 12: Market trends
- PART 13: Vendor Landscape
- PART 14: Key vendor analysis
- PART 15: Appendix
A complete report of the Celiac Disease Drugs Market Research is available at the Research and Markets website. Have a copy of it and get great insights from the celiac disease drugs market analysis.
- The report predicts that the global celiac disease drugs market is expected to grow at a CAGR of 24.22 for a time period of 2017 – 2021.
- Market challenges as depicted from the report show that high prices, stringent regulations as well as contamination issues which lead to product recalls are key challenges involved in the market.
- Growing awareness about health benefits of gluten-free food is also a key factor to market drive.